Literature DB >> 6256393

Turnover of the surface proteins and the receptor for serum asialoglycoproteins in primary cultures of rat hepatocytes.

R Warren, D Doyle.   

Abstract

The turnover of plasma membrane proteins in primary rat hepatocyte cultures was examined by following the loss of polypeptides labeled in situ by lactoperoxidase-catalyzed iodination using 125I and 131I. Most plasma membrane proteins had similar rates of degradation, having a half-life of approximately 85 h. By in situ labeling via lactoperoxidase-catalyzed iodination, as well as metabolically labeling cells with L-[35S]methionine, the asialoglycoprotein receptor, a plasma membrane constituent, was identified and shown to exist in three forms which were structurally related. The turnover of receptor on the cell surface was examined by following the loss of iodinated cell surface receptor, while the turnover of total cellular receptor, including both surface and internally localized receptor was assayed by following the loss of receptor labeled metabolically with [35S]methionine. The turnover rate in both cases was approximately 20 h. Receptor-mediated endocytosis of asialoglycoproteins had no effect on the turnover of the plasma membrane proteins or receptor. Based on estimates of the rate of metabolism of the asialoglycoprotein ligand relative to the turnover rate of the receptor, we conclude each molecule of receptor can deliver about 1,000 molecules of ligand to the lysosome to be degraded.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6256393

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Assembly of a heterooligomeric asialoglycoprotein receptor complex during cell-free translation.

Authors:  J T Sawyer; D Doyle
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

Review 2.  When trafficking and signaling mix: How subcellular location shapes G protein-coupled receptor activation of heterotrimeric G proteins.

Authors:  Braden T Lobingier; Mark von Zastrow
Journal:  Traffic       Date:  2019-02       Impact factor: 6.215

3.  Receptor-mediated endocytosis of asialoglycoproteins by rat liver hepatocytes: biochemical characterization of the endosomal compartments.

Authors:  D A Wall; A L Hubbard
Journal:  J Cell Biol       Date:  1985-12       Impact factor: 10.539

4.  Capacity limits of asialoglycoprotein receptor-mediated liver targeting.

Authors:  Charlotte Bon; Thomas Hofer; Alain Bousquet-Mélou; Mark R Davies; Ben-Fillippo Krippendorff
Journal:  MAbs       Date:  2017-09-06       Impact factor: 5.857

Review 5.  Endocytosis and the recycling of plasma membrane.

Authors:  R M Steinman; I S Mellman; W A Muller; Z A Cohn
Journal:  J Cell Biol       Date:  1983-01       Impact factor: 10.539

6.  Fate of receptor and ligand during endocytosis of asialoglycoproteins by isolated hepatocytes.

Authors:  K Bridges; J Harford; G Ashwell; R D Klausner
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

7.  Biosynthesis and turnover of the phosphomannosyl receptor in human fibroblasts.

Authors:  K E Creek; W S Sly
Journal:  Biochem J       Date:  1983-08-15       Impact factor: 3.857

8.  Specific binding of leukotriene C4 to ileal segments and subcellular fractions of ileal smooth muscle cells.

Authors:  S Krilis; R A Lewis; E J Corey; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

9.  Comparison of the degradative fate of monoamine oxidase in endogenous and transplanted mitochondrial outer membrane in rat hepatocytes. Implications for the cytomorphological basis of protein catabolism.

Authors:  P J Evans; R J Mayer
Journal:  Biochem J       Date:  1984-04-01       Impact factor: 3.857

10.  Human IgA as a heterovalent ligand: switching from the asialoglycoprotein receptor to secretory component during transport across the rat hepatocyte.

Authors:  J M Schiff; M M Fisher; A L Jones; B J Underdown
Journal:  J Cell Biol       Date:  1986-03       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.